S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.07%) $10.83
USD/GBP
(-0.15%) $0.791
USD/RUB
(-0.09%) $92.49

Realtime updates for Spago Nanomedical AB [SPAGO.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:52

0.00% SEK 0.290

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:52):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project...

Stats
Today's Volume 277 900
Average Volume 146 068
Market Cap 65.17M
EPS SEK-0.0747 ( 2023-11-03 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.720
ATR14 SEK0.00400 (1.38%)

Spago Nanomedical AB Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Spago Nanomedical AB Financials

Annual 2023
Revenue: SEK1.20M
Gross Profit: SEK-22.75M (-1 890.86 %)
EPS: SEK-0.430
Q4 2023
Revenue: SEK731 000
Gross Profit: SEK-5.01M (-684.95 %)
EPS: SEK-0.0792
Q3 2023
Revenue: SEK271 000
Gross Profit: SEK-2.22M (-820.30 %)
EPS: SEK-0.0747
Q2 2023
Revenue: SEK114 000
Gross Profit: SEK-2.68M (-2 350.88 %)
EPS: SEK-0.0900

Financial Reports:

No articles found.

Spago Nanomedical AB

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators